Skip to content

Hemoglobin Levels for Blood Transfusions During and After Surgery

Threshold for Operative and Postoperative Hemoglobin Trigger for Red Blood Cell Transfusion: A Pilot Randomized Controlled Trial (TOPGUN-Pilot)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06718439
Acronym
TOPGUN-Pilot
Enrollment
384
Registered
2024-12-05
Start date
2025-04-16
Completion date
2027-01-15
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Transfusion, Surgery

Keywords

Red blood cell transfusion, hemoglobin threshold, blood loss management, liberal transfusion practice, restrictive transfusion practice, intraoperative

Brief summary

The goal of this pilot clinical trial is to learn if it is achievable to conduct a large-scale clinical trial whereby, the investigators will compare two ways of deciding when to give a blood transfusion during surgery. Participants in this study are adults undergoing surgery with a risk of significant blood loss. The main question it aims to answer is: * Is a trial designed to definitively test and compare two different red blood cell transfusion strategies feasible? Participants will: * Receive blood transfusions during surgery based on a higher (less than 90 g/L) or a lower (less than 70 g/L) hemoglobin value. * Complete questionnaires at 30 and 90 days after surgery.

Detailed description

During some surgeries, there is a risk of significant blood loss. To manage this, blood transfusions may be needed to replace lost blood. Transfusion strategies during surgery vary among physicians and hospitals. Current guidelines are broad and suggest it is okay to limit blood transfusions during surgery. However, some anesthesiologists worry that not giving enough blood might cause problems for patients. On the other hand, many cancer surgeons are concerned that giving too much blood could lead to worse outcomes for cancer patients. This difference in opinions shows why clinical trials are needed to guide future practices. The purpose of this study is to test a new protocol that is designed to definitively test and compare two different red blood cell transfusion strategies. It is hypothesized that this trial will be deemed feasible. TOPGUN-Pilot is a pragmatic, individually randomized, parallel-arm, vanguard, randomized controlled trial. If feasibility is demonstrated, patients enrolled in the vanguard pilot will be rolled into the definitive TOPGUN trial. This trial is meant to be pragmatic in nature, whereby the study protocol is simple to implement, outcomes are relevant to patients, physicians, and healthcare administrators, and data collection is limited. Management of patients prior to, during, and after the intraoperative transfusion strategies will be at the discretion of individual practitioners. A total of 384 patients will be randomized across 3 hospitals (4 sites) in Ontario and Quebec.

Interventions

Red blood cell transfusion when the participant's hemoglobin level is measured below 70 g/L or to maintain a hemoglobin target range of 70-80 g/L. This strategy will be adhered to during surgery and up to 6 hours in the post-operative anesthesia care unit.

Red blood cell transfusion when the participant's hemoglobin level is measured below 90 g/L or to maintain a hemoglobin target range of 90-100 g/L. This strategy will be adhered to during surgery and up to 6 hours in the post-operative anesthesia care unit.

Sponsors

Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients, age ≥18. * Elective or urgent surgery. * Risk of red blood cell transfusion of at least 10 percent. * Preoperative hemoglobin of less than 130 g/L. * Intraoperative hemoglobin of ≤ 100 g/L at any time during surgery.

Exclusion criteria

* Active major hemorrhage as indication for surgery (e.g. ruptured aneurysm, polytrauma, etc.). * Acute coronary syndrome or myocardial infarction within the past 6 weeks. * Cardiac surgery. * Liver transplantation. * Surgery for moderate to severe (Glasgow Coma Scale (GCS) score ≤ 12) traumatic brain injury. * Pregnancy or obstetrical surgery. * Patient refusal of blood products. * Inability to provide consent.

Design outcomes

Primary

MeasureTime frameDescription
Recruitment rate12 months post site initiationRecruitment of ≥8 patients per month per site for one year.
Intervention adherenceFrom enrollment up to 6 hours in the Post-Anesthetic Care UnitIntervention adherence of at least 85%.
Participant retentionFrom randomization to 30 days post surgery.Retention of at least 90% of participants with completion of 30-day effectiveness outcomes.

Countries

Canada

Contacts

Primary ContactZanna Vanterpool, MSc
zvanterpool@ohri.ca6137378899

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026